Summit Therapeutics (SMMT) Share-based Compensation (2014 - 2026)
Summit Therapeutics (SMMT) reported Share-based Compensation of $47.69 million for Q3 2026, down 63.5% from $130.76 million a year earlier and down 30.6% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Summit Therapeutics' Share-based Compensation came in at $300.96 million, down 52.4% year-over-year; for FY2025, it was $732.42 million.
- Share-based Compensation has a five-year compound annual growth rate of 233.9% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $50.98 million in FY2024 (+261.4%), $14.11 million in FY2023 (+18.1%), $11.95 million in FY2022 (-6.7%) and $12.8 million in FY2021 (+625.0%).
- The Q3 2026 figure ranks as the lowest quarterly Share-based Compensation since Q1 2025.
- Year over year, Share-based Compensation gained in five of the last seven quarters, with growth averaging 277.0%.
- The high point for year-over-year Share-based Compensation in five years was Q4 2025 (growth of 914.8%); the low point was Q2 2026 (a decline of 85.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $68.71 million (Q2 2026), $72.79 million (Q1 2026) and $111.78 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - | 47.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 47.69 Mn |
| Jun 30, 2026 | 68.71 Mn |
| Mar 31, 2026 | 72.79 Mn |
| Dec 31, 2025 | 111.78 Mn |
| Sep 30, 2025 | 130.76 Mn |
| Jun 30, 2025 | 478.78 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 11.02 Mn |
| Sep 30, 2024 | 19.37 Mn |
| Jun 30, 2024 | 11.09 Mn |
| Mar 31, 2024 | 9.51 Mn |
| Dec 31, 2023 | 8.75 Mn |
| Sep 30, 2023 | 705,000.00 |
| Jun 30, 2023 | 1.88 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 2.66 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 5.62 Mn |
API Access
Summit Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();